Mergers & Acquisitions
What does Facebook’s $2B Oculus buy bring to healthcare? | MassDevice.com On Call
MASSDEVICE ON CALL — New Facebook (NSDQ:FB) target Oculus VR may have some important offerings for the healthcare world, especially in imaging-based diagnostics and immersive rehabilitation therapy.
Stryker closes $120M Patient Safety Tech buy
Stryker (NYSE:SYK) closed its $2.22-per-share buyout of California safety-sponge maker Patient Safety Technologies in a deal valued at about $120 million.
Smiths Medical is off the block after dismal H1 earnings
Varian to acquire cancer software maker Velocity Medical
Varian Medical (NYSE:VAR) said it inked a deal to acquire Velocity Medical Solutions’ cancer clinic software.
Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M
Imaging technologies company Digirad Corp.(NSDQ:DRAD) acquired out-sourced cardiac monitoring services provider Telerhythmics in a deal worth up to $4.1 million.
Sorin drops $20M on Oscor’s cardiac lead biz
Sorin Group (BIT:SRN) said it agreed to put $20 million down on Oscor’s cardiac lead manufacturing business as it gears up to develop MRI-safe leads.
Medical Action Industries sells Medegen unit to Inteplast for $75M
Medical Action Industries (NSDQ:MDCI) said it inked a deal with Inteplast Group’s Medira Inc. to sell its Medegen Medical Products subsidiary for $75 million.
Covidien’s ev3 seeks new trial in $175M loss to Appriva
Report: Medtech mergers, FDA approvals tank in ‘unlucky’ 2013
Last year was a tough one for the medical device industry, with acquisition activity down, M&A dollars cut in half and FDA approvals slashed, but at least it wasn’t the worst year that medtech has faced in the last decade – 2009 still holds that title.